0000899243-19-017924.txt : 20190624
0000899243-19-017924.hdr.sgml : 20190624
20190624160746
ACCESSION NUMBER: 0000899243-19-017924
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190620
FILED AS OF DATE: 20190624
DATE AS OF CHANGE: 20190624
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krognes Steve E.
CENTRAL INDEX KEY: 0001666236
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37719
FILM NUMBER: 19915324
MAIL ADDRESS:
STREET 1: 863 MITTEN ROAD, SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corvus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001626971
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464670809
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: (650) 900-4520
MAIL ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-20
0
0001626971
Corvus Pharmaceuticals, Inc.
CRVS
0001666236
Krognes Steve E.
C/O CORVUS PHARMACEUTICALS, INC.
863 MITTEN ROAD, SUITE 102
BURLINGAME
CA
94010
1
0
0
0
Stock Option (Right to Buy)
3.61
2019-06-20
4
A
0
15000
0.00
A
2029-06-20
Common stock
15000
15000
D
The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2020 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.
/s/ Leiv Lea, as Attorney-in-Fact for Steve E. Krognes
2019-06-24